 | |
| Clinical data | |
|---|---|
| Other names | 4-Hydroxy-pyr-tryptamine; 4-Hydroxy-N,N-tetramethylenetryptamine; 1-[2-[3-(4-Hydroxy)indolyl]ethyl]pyrrolidine; 4-Hydroxypyrrolidyltryptamine; 3-[2-(1-Pyrrolidyl)ethyl]-4-indolol |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H18N2O |
| Molar mass | 230.311 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
4-HO-pyr-T, also known as 4-hydroxy-N,N-tetramethylenetryptamine, is a lesser-known psychedelic drug of the tryptamine family. [1] [2] It is the 4-hydroxyl analogue of pyr-T. [2] 4-HO-pyr-T was first synthesized by Alexander Shulgin. In his 1997 book TiHKAL (Tryptamines I Have Known and Loved), neither the dose nor the duration are reported. [1] 4-HO-pyr-T produces few to no effects. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-HO-pyr-T. [1]
Contents
Derivatives and analogues of 4-HO-pyr-T, for instance analogues with an azetidine instead of pyrrolidine ring, have been synthesized and described. [3]
